CHAIRS

Cheryl Ho, MD, FRCP(C)

Cheryl Ho, MD, FRCPC

Clinical Associate Professor
University of British Columbia
Medical Oncologist
British Columbia Cancer
Vancouver, BC

Cheryl Ho, MD is a medical oncologist at BC Cancer and Clinical Associate Professor at the University of British Columbia. Her clinical practice focuses on thoracic and head & neck malignancies. Dr. Ho evaluates the impact of therapies proven in clinical trials in the real world through population-based analysis. Her current focus is on developing a learning health care system with a real-world data evidence-generation framework to inform healthcare decision-makers.

Barbara Melosky, MD, FRCP(C)

Professor of Medicine, UBC
Medical Oncologist, BC Cancer
Vancouver, BC

Dr. Melosky is a Professor of Medicine at the University of British Columbia and a Medical Oncologist in Vancouver at BC Cancer. She graduated from medical school at the University of Manitoba and did a residency in internal medicine and an oncology fellowship at the University of British Columbia. Dr. Melosky specializes in the field of thoracic malignancy. She sits on the Executive Lung Site Committee for CCTG Canadian Clinical Trials Group.

Her main focus of clinical trials is on EGFR inhibitors; she is published in this area and is considered a national and international expert. Dr. Melosky has chaired the Canadian Lung Cancer Conference for the last 12 years, which is attended by over 350 participants. She chairs and organized the multi-disciplinary Lung Cancer Journal Club three times yearly. She is chair and created the British Columbia Lung Cancer Biobank.

She is also the chairperson of the Colorectal Screening Program of British Columbia and has a special interest in EGFR receptors and management of side effects.

Randeep Sangha, MD, FRCPC

Medical Oncologist, Cross Cancer Institute
Associate Professor, University of Alberta
Edmonton, AB

Dr. Sangha is an Associate Professor in the Department of Oncology at the University of Alberta and Medical Oncologist at the Cross Cancer Institute, Edmonton, AB. He is the Provincial Lead for the Alberta Lung Cancer Program.

Dr. Sangha received his medical degree at the University of Alberta and subsequently specialized in Internal Medicine and Medical Oncology. He completed two years of post-fellowship training in thoracic oncology at the University of California, Davis Comprehensive Cancer Center.

His academic, clinical, and educational activities revolve around thoracic and hematological malignancies. He is also experienced in Investigational New Drug (Phase I) development and is actively involved in the Phase I clinical trials program at the Cross Cancer Institute.

Devin Schellenberg, MD, FRCS(C)

Clinical Associate Professor – UBC
Department Head, Radiation Oncology
BC Cancer – Surrey Centre

Dr. Devin Schellenberg completed medical school and Residency at the University of BC and University of Toronto.  He went onto a Fellowship at Stanford University and has been the Department Head of Radiation Oncology at the BC Cancer Surrey Centre for the past 4 years. He chairs the Lung Radiation Oncology working group with CCTG and is a founding member of CAPRI (Canadian Pulmonary Radiotherapy Investigators Group).

He has been a leader in BC Cancer’s Stereotactic Ablative Body Radiotherapy (SABR) programs and his current research efforts focus on how radiation can alter the course of metastatic disease and (outside of cancer) whether radiation is able to treat heart arrhythmias.

FACULTY

David E. Dawe, BASc MD MSc FRCPC

Assistant Professor, University of Manitoba
Medical Oncologist, CancerCare Manitoba
Affiliate Scientist, CancerCare Manitoba Research Institute

Dr. David Dawe is a medical oncologist at CancerCare Manitoba, assistant professor at the University of Manitoba, and affiliate scientist at the CancerCare Manitoba Research Institute.  He completed his medical oncology training in Manitoba and treats thoracic cancers. He leads research focused on investigating lung cancer treatment patterns and outcomes to identify opportunities for system improvement. His research also investigates real world outcomes and biomarkers for frail and older patients with cancer.

Pierre-Olivier Gaudreau, MD, PhD, MPs, FRCPC

Senior Investigator, IND/ Lung DSC, Canadian Cancer Trials Group|
Assistant Professor, Department of Oncology, Queen’s University
Medical Oncologist, Cancer Centre of Southeastern Ontario
Canadian Cancer Trials Group / Queen’s University
Toronto, ON

Dr. Gaudreau completed his internal medicine, hematology and medical oncology residency at the University of Montreal. Following his clinical training, he got involved in a PhD program co-mentored by Dr. Don L. Gibbons and Dr. Jennifer A. Wargo at the MD Anderson Cancer Center as well as by Dr. John Stagg at the CHUM Research Center. His PhD thesis focused on immune checkpoint blockade resistance mechanisms in the context of non-small cell lung cancer, and featured both fundamental sciences as well as early phase clinical trials. He has since joined the CCTG as a Senior Investigator for the Thoracic Oncology Disease Site Committee and the Investigational New Drug Program. In addition, he practices as a thoracic medical oncologist at the Kingston Health Sciences Centre.

Professor Jin Mo Goo, MD, PhD

Professor, Department of Radiology
Seoul National University Hospital
Seoul, Korea

Jin Mo Goo is Professor in the Department of Radiology, Seoul National University Hospital, Seoul, Korea. He received the MD and PhD degrees from Seoul National University. Dr. Goo is Treasurer of Fleischner Society and has participated in publishing several guidelines on chest imaging. He is also associate editor of Radiology and Journal of Thoracic Imaging, and is imaging subcommittee chair in the staging and prognostic factors committee in the International Association for the Study of Lung Cancer. He is currently President of the Korean Society of Thoracic Radiology. His main research interests include the application of computer-aided diagnosis systems, quantitative analysis of imaging and the evaluation of lung nodules. Dr. Goo has published more than 300 articles in the English-language, peer-reviewed journals.

Kristen Haase, RN PhD

Assistant Professor at the School of Nursing
University of British Columbia,
Vancouver, BC

Kristen Haase, RN PhD (she/her/hers) is an Assistant Professor at the School of Nursing at UBC and an affiliated researcher in the Fraser Health Authority. Her research program centres on supporting older adults as they manage cancer, chronic disease, and wellbeing, in domains of symptom science, self-management, and technology-enabled interventions.

Magali Lecavalier-Barsoum, M.D., FRCP(C)

Assistant Professor, Oncology Department
McGill University
Department of Oncology, Division of Radiation Oncology
Jewish General Hospital
Montreal, QC

Dr Lecavalier-Barsoum did her residency at McGill and a 2-year fellowship and Masters at the Princess Margaret Hospital in Toronto. She works at the Jewish General Hospital since 2017, where she treats thoracic, gyne, GI and breast malignancies. She is the site director of the Radiation Oncology Program at the Jewish General Hospital and the fellowship co-director. She is involved in clinical and basic science research projects

Dr. Billy W. Loo, Jr., M.D., Ph.D 

Professor of Radiation Oncology
Dept. of Radiology, Stanford (MIPS)
Physician-Scientist, Radiation Oncologist, Bioengineer
Director, Thoracic Radiation Oncology Program
Stanford, CA

Billy W. Loo, Jr., M.D., Ph.D. is a Professor of Radiation Oncology, a member of the Molecular Imaging Program at Stanford (MIPS) in the Department of Radiology, and a member of the Stanford Cancer Institute, in the School of Medicine. He is a physician-scientist Radiation Oncologist and Bioengineer who directs the Thoracic Radiation Oncology Program at Stanford.

His clinical specialties are state-of-the-art radiation therapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR) and 4-D image-guided radiation therapy for lung tumors. Dr. Loo is a recognized expert in thoracic cancers serving on multiple national committees (including as writing member, chair, or vice-chair) that publish clinical guidelines on the treatment of lung cancer and other thoracic malignancies, including the National Comprehensive Cancer Network (NCCN), American College of Radiology (ACR), and American Society of Radiation Oncology (ASTRO).

His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer, and development of new medical imaging methods for measuring organ function and predicting response to cancer treatment. As part of this work, he leads a clinical and preclinical research program in molecular imaging, particularly using novel PET tracers for tumor hypoxia (EF5), tumor proliferation (FLT), and neuroinflammation (PBR06). He also co-leads clinical trials of novel applications of SABR including treatment of pulmonary emphysema and cardiac arrhythmias.

Since conceiving of a fundamentally new approach to delivering ultra-rapid, ultra-precise radiation therapy, pluridirectional high-energy agile scanning electronic radiotherapy (PHASER), Dr. Loo’s major laboratory research focus has been to co-lead a collaborative effort between the Stanford Cancer Institute and SLAC National Accelerator Laboratory to develop PHASER into a transformative yet clinically practical technology. This program comprises both technology development and fundamental research on the radiobiology of extremely rapid FLASH radiation therapy to optimize the biological therapeutic index.

Dr. Loo received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Oncology residency training at Stanford University. He is certified by the American Board of Radiology in Radiation Oncology.

Rana Jin, RN, DNP, CON(C)

Clinical Nurse Specialist, Older Adults with Cancer Clinic (OACC)
Princess Margaret Cancer Center
Toronto, ON

Rana is a clinical nurse specialist in the Older Adults with Cancer Clinic at the Princess Margaret Cancer Centre, Canada, and has had the privilege of being a part of this clinic since its existence in 2015. Rana recently finished her Doctorate of Nursing Practice in 2021, and her thesis focused on proactive follow-up for older adults with cancer after systemic therapy in order to decrease unplanned health care utilization. Rana has her Canadian Certification in Oncology Nursing, is an active member of the Canadian Association of Nurses in Oncology (CANO) and the International Society of Geriatric Oncology (SIOG). Rana was awarded the 2019 Boehringer Ingelheim Oncology Nurse of the Year Award, Canada, and the 2019 Saul and Esther Baker Award Recipient for her outstanding contributions in the care of older patients across Mount Sinai and the University Health Network Hospitals.

Meredith Giuliani, MBBS, MEd, PhD, FRCPC

Associate Professor, Department of Radiation Oncology
University of Toronto
Director of Education, Princess Margaret Cancer Centre
Toronto, ON

Dr Meredith Giuliani  is an Associate Professor in the Department of Radiation Oncology at the University of Toronto and the Director of Education at Princess Margaret Cancer Centre.

Dr Giuliani received her MBBS qualification from the University of London, England and she then competed her residency training in radiation oncology at the University of Toronto. She received her Master’s of Education from the Ontario Institute of Sciences in Education at the University of Toronto and her PhD from the School of Health Professions Education at Maastricht University. Her PhD focused on globalization and the influence of neocolonialism on oncology curricula. Her education research activity focuses on globalization, the influence of education on health systems and the intersection of education and health disparities. Her clinical interests are in thoracic cancers.

Schroder Sattar, RN, PhD  

Assistant Professor
College of Nursing, University of Saskatchewan
Saskatoon, SK

Schroder Sattar is a registered nurse and an Assistant Professor at the College of Nursing, University of Saskatchewan, Canada. Her research focuses on functional performance, falls, and exercise intervention in older adults with cancer. Currently, Schroder is conducting a randomized controlled trial to investigate the efficacy of a virtually delivered exercise program on improvement of lower body strength, balance, and fall rates in older adults with cancer. She has presented her work in various national and international conferences.  

Paula Ugalde, MD

Associate Thoracic Surgeon, Brigham and Women’s Hospital
Member of the Faculty, Harvard Medical School
Boston, MA

Dr. Paula Ugalde Figueroa graduated from the medical school of the Federal University of Bahia in Salvador, BA, Brazil. She did her general surgical residency at Santo Antônio Hospital-Irmã Dulce, a university-affiliated hospital also in Salvador, and her thoracic surgery residency at Santa Casa da Misericórdia Hospital in Porto Alegre RS, Brazil. Additionally, she did postdoctoral research at Santa Casa da Misericórdia Hospital and the Federal University of Bahia and obtained a master’s degree in Internal Medicine in 2004. She was an assistant professor in the Department of Internal Medicine, Division of Pneumology at the Federal University of Bahia Medical School from 2001 to 2005. From 2005 to 2007, Dr. Ugalde did a clinical fellowship in thoracic surgery at Centre de Pneumologie et de Chirurgie Thoracique Hôpital Laval in Quebec, Canada. In the 2007-2008 academic year, she studied at the University of Pittsburgh Medical Center under Dr. James D. Luketich, completing a Minimally Invasive Thoracic Surgery Fellowship.
In 2013, she was recruited back to Quebec and began her tenure as an associate professor in the Department of Surgery at Laval University. She was named director of the Thoracic Oncology research program of the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) at Laval University in 2015 and was promoted to clinical professor in 2019.
Dr. Ugalde established herself as a thoracic surgeon dedicated to research. She has an extensive record of publications including an impressive body of work on thoracic surgery using innovative uniportal VATS approaches for lung cancer. She has also participated in Canadian national clinical research groups. Dr. Ugalde oversaw the creation of the lung cancer database at Laval University, and under her guidance the university became the largest contributor in the world of cases to the prospective database maintained by the International Association for the Study of Lung Cancer (IASLC). She was awarded the Clifton F. Mountain Lectureship Award for Staging from the IASLC in 2019, and due to this effort, she was appointed Chair of the Database Committee of Staging and Prognostic Factors Committee of the IASLC in 2019. In 2019, Dr. Ugalde was accepted as a member of the American Association of Thoracic Surgery (AATS) and in 2021 as member of the STS. In 2021, she was also nominated Board Director of the IASLC.
She has performed peer-review for the society’s journals as well as for other journals including the European Journal of Cardiothoracic Surgery, and given lectures at AATS symposia and worldwide. Additionally, she has helped introduce minimally invasive thoracic surgery in Brazil and Latin America through courses and one-on-one mentoring, including a teaching a Latin American fellow in Quebec each year who then returns to his or her home country. Additionally, Dr. Ugalde pursues this mission as co-chair of International Affairs for the Women in Thoracic Surgery society.